Details for 2014722443
Up to date per 03.04.2026
Actions
Details for 2014722443
Granted/Registered
European Patent
20.01.2016 A
06.09.2017 B1
14.03.2013
US
201361785608 P
14.03.2013
US
201361786086 P
18.07.2013
US
201361847780 P
22.07.2013
US
201361856847 P
27.09.2013
US
201361883843 P
27.09.2013
US
201361883798 P
19.02.2014
US
201461941798 P
13.03.2014
AR
P014100970
C07D 405/12 20060101AFI20170109BHEP
Owner
Onyx Therapeutics, Inc.One Amgen Center Drive Thousand Oaks, CA 91320-1799US
Representative
Representative
Kliment & Henhapel Patentanwälte OGGonzagagasse 151010 WienAT
Inventor
MCMINN, Dustin255 Kent Road Pacifica, CA 94044US
JOHNSON, Henry360 Hazel Avenue San Bruno, CA 94066US
BOWERS, Simeon3252 Bridsall Avenue Oakland, CA 94619US
MOEBIUS, David, C.804 Balboa Lane Foster City, CA 94404US
Information about Fees